AM-928
- Generic Name
- AM-928
Safety of AM-928 Infusion in Advanced Solid Tumors
- First Posted Date
- 2023-01-18
- Last Posted Date
- 2025-02-04
- Lead Sponsor
- AcadeMab Biomedical Inc.
- Target Recruit Count
- 38
- Registration Number
- NCT05687682
- Locations
- 🇨🇳
National Taiwan University Hospital, Taipei, Taiwan
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath